Advanced search

Effects of the low molecular weight heparin nadroparin on tumour associated angiogenesis

ISABELLE DEBERGH (UGent), Nancy Van Damme (UGent), Marc Peeters (UGent), Piet Pattyn (UGent) and Wim Ceelen (UGent)
(2008) Annals of Oncology. 19(Suppl 6). p.176-176
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
DEBERGH, ISABELLE, Nancy Van Damme, Marc Peeters, Piet Pattyn, and Wim Ceelen. 2008. “Effects of the Low Molecular Weight Heparin Nadroparin on Tumour Associated Angiogenesis.” In Annals of Oncology, 19:176–176.
APA
DEBERGH, I., Van Damme, N., Peeters, M., Pattyn, P., & Ceelen, W. (2008). Effects of the low molecular weight heparin nadroparin on tumour associated angiogenesis. Annals of Oncology (Vol. 19, pp. 176–176).
Vancouver
1.
DEBERGH I, Van Damme N, Peeters M, Pattyn P, Ceelen W. Effects of the low molecular weight heparin nadroparin on tumour associated angiogenesis. Annals of Oncology. 2008. p. 176–176.
MLA
DEBERGH, ISABELLE, Nancy Van Damme, Marc Peeters, et al. “Effects of the Low Molecular Weight Heparin Nadroparin on Tumour Associated Angiogenesis.” Annals of Oncology. Vol. 19. 2008. 176–176. Print.
@inproceedings{429054,
  author       = {DEBERGH, ISABELLE and Van Damme, Nancy and Peeters, Marc and Pattyn, Piet and Ceelen, Wim},
  booktitle    = {Annals of Oncology},
  language     = {eng},
  number       = {Suppl 6},
  pages        = {176--176},
  title        = {Effects of the low molecular weight heparin nadroparin on tumour associated angiogenesis},
  volume       = {19},
  year         = {2008},
}